Implantica publishes Year-end Report, January – December 2023 (Q4)
RefluxStop™ – Gaining speed, breaking boundaries and going globalSignificant events in the fourth quarter of 2023 · Selected U.S. surgeons begin the standardized RefluxStop™ surgery training program · in preparation for Cadaver Usability study during Q1 2024 · from over 10 key centers in U.S. · results to be used in our PMA application to FDA · Successful 2nd Annual RefluxStop™ Users Meeting · > 50 participants attended · surgeons and GIs from U.S., Canada, U.K. and across Europe · RefluxStop™ cost-effectiveness research received top recognition at